cho_logo_symbol_border
  • (800) 266-7207 | 30 Wall St. 8th Floor New York, NY 10005
  • Mon - Fri: 8:00 am - 5:00 pm

Study: Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers

143 Views0 Comments

By: Sebastian Havervall, Axel Rosell, Mia Phillipson, Sara M Mangsbo, Peter Nilsson, Sophia Hober, Charlotte Thålin
Published May 18 2021

JAMA Network

    Full Study

    This cohort study describes COVID-19–related symptoms persisting 8 months after SARS-CoV-2 infection among Swedish health care workers and self-reported effects of the residual symptoms on respondents’ home, work, and social function.

    An external file that holds a picture, illustration, etc. Object name is jama-e215612-g001.jpg
    COVID-19–Related Long-term Functional ImpairmentThe percentage of seropositive (n = 323) and seronegative (n = 1072) participants reporting symptoms lasting at least 2 months and their related functional impairment in their work, social, and home life using the Sheehan Disability Scale (1-3, mild; 4-6, moderate; and 7-10, marked).

    Leave A Comment

    Your email address will not be published. Required fields are marked *

    Disclaimer

    Clear Health Pass Safe Harbor Exemption
    The information on this website does not constitute an offer to sell or solicitation of an offer to buy securities by anyone in any jurisdiction which would be considered unlawful. Clear Health Pass Holdings, LLC’s offering is under Rule 506(c) of Regulation D and is considered a “safe harbor” for the private offering exemption of Section 4(a)(2) of the Securities Act. To be eligible to receive qualified investment status, you must be an accredited investor as defined by Section 2(15)(ii) of the Securities Act of 1933.

    © 2023 Clear Health Pass Holdings™, LLC., All trademark references are trademarks of either the Clear Health Pass Holdings, LLC or their respective owners.

     

    Our Journey to $1B+ Valuation

     

    Disrupting Healthcare Testing / Diagnostics Early Detection of Cancer,
    Chronic Conditions, Disease, Unlocking Anti-Aging Genomics & Promoting Longevity.

     

    FUNDING GOAL $5,000,000

    Funding Goal $5,000,000

    20%

    Click here to Download Our Investment Package

    Skip to content